Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine
Clinical trial NCT04530357 · COMPLETED
Trial details
- NCT number
- NCT04530357
- Sponsor
- Research Institute for Biological Safety Problems
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-19
- Primary completion
- 2020-11-25
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.